NCT04068597 2025-12-18Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesCellCentric Ltd.Phase 1/2 Recruiting250 enrolled
NCT01592370 2025-10-22An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple MyelomaBristol-Myers SquibbPhase 1/2 Completed320 enrolled 35 charts
NCT02228512 2018-08-31Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated LymphomasNational Institutes of Health Clinical Center (CC)Phase 1/2 Withdrawn